Chargement en cours...
Ticagrelor breaks up the tumor-platelet party
In this issue of Blood, Cho et al demonstrate that blocking adenosine 5′-diphosphate (ADP) signaling to the P2Y12 receptor on platelets reduces the growth of ovarian cancer cells, implicating the P2Y12 inhibitor ticagrelor as a potential therapeutic option for primary and secondary prevention of ova...
Enregistré dans:
| Publié dans: | Blood |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606010/ https://ncbi.nlm.nih.gov/pubmed/28882833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-07-795898 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|